ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A.

MLA

Shrestha, Prabhat, et al. “ROS-Responsive Thioketal Nanoparticles Delivering System for Targeted Ulcerative Colitis Therapy with Potent HDAC6 Inhibitor, Tubastatin A.” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, vol. 201, Oct. 2024, p. 106856. EBSCOhost, https://doi.org/10.1016/j.ejps.2024.106856.

APA

Shrestha, P., Duwa, R., Lee, S., Kwon, T. K., Jeong, J.-H., & Yook, S. (2024). ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 201, 106856. https://doi.org/10.1016/j.ejps.2024.106856

Chicago

Shrestha, Prabhat, Ramesh Duwa, Sooyeun Lee, Taeg Kyu Kwon, Jee-Heon Jeong, and Simmyung Yook. 2024. “ROS-Responsive Thioketal Nanoparticles Delivering System for Targeted Ulcerative Colitis Therapy with Potent HDAC6 Inhibitor, Tubastatin A.” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 201 (October): 106856. doi:10.1016/j.ejps.2024.106856.